Hong Kong Island, Hong Kong, China In 2015 was created GT Healthcare Capital Partners, which is appeared as VC. The main department of described VC is located in the Hong Kong. The fund was located in Asia if to be more exact in Hong Kong.
The fund was created by Alan Au. Besides them, we counted 4 critical employees of this fund in our database.
The important activity for fund was in 2019. Speaking about the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in 2-6 investment rounds annually. The typical startup value when the investment from GT Healthcare Capital Partners is more than 1 billion dollars.
For fund there is no match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Health Care, Medical Device. Among the most popular portfolio startups of the fund, we may highlight Oxford Nanopore Technologies, Oxford VR, Ultromics. The fund has specific favorite in a number of founders of portfolio startups.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the GT Healthcare Capital Partners, startups are often financed by Venrock, Sofinnova Partners, Pfizer Venture Investments. The meaningful sponsors for the fund in investment in the same round are Sonder Capital, Oxford Sciences Innovation, Vertex Ventures. In the next rounds fund is usually obtained by Oxford Finance LLC, Hostplus, GIC.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Anhui Kexun Venture Capital | - |
| Arris Group | Georgia, Suwanee, United States |
| B37 Ventures | California, San Francisco, United States |
| BizTEC | Hefa, Hefa, Israel |
| Blackbelt Properties | - |
| Capitech | China, Shaanxi, Xian Shi |
| Cirrus Logic | Austin, Texas, United States |
| Diversified Systems | Kenilworth, New Jersey, United States |
| GWN Ltd | - |
| HSBC Securities | New York, New York, United States |
| Invaluable | Allston, Massachusetts, United States |
| Lanying Materials Trade | China, Jiangsu, Suzhou |
| Lichtsteiner Foundation | Bern, Berne, Switzerland |
| Monachil Capital Partners LP | Connecticut, Greenwich, United States |
| Mosaix Ventures | Chicago, Illinois, United States |
| Rally Capital | - |
| RedMetal | Massachusetts, United States, Watertown |
| Shenzhen Renyuan Guoying Touzi Guanli Qiye (Youxian Hehuo) | China, Guangdong, Shenzhen |
| St George Bank | Australia, New South Wales, Sydney |
| Zhonglian Investment Holdings | China, Shanghai |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Autobahn Therapeutics | $100M | 24 Jul 2024 | San Diego, California, United States | ||
Moon Surgical | $55M | 17 May 2023 | Paris, Ile-de-France, France | ||
Moon Surgical | $31M | 07 Jun 2022 | Paris, Ile-de-France, France | ||
| $105M | 28 Apr 2021 | San Diego, California, United States | |||
Exscientia | $40M | 04 Mar 2021 | Oxford, England, United Kingdom | ||
G.I. Windows | $16M | 19 Aug 2020 | Massachusetts, United States | ||
Exscientia | $60M | 26 May 2020 | Oxford, England, United Kingdom | ||
Oxford VR | $13M | 12 Feb 2020 | United Kingdom, England | ||
G.I. Windows | $14M | 11 Dec 2019 | Massachusetts, United States |
– Exscientia is an Oxford, England, UK-based clinical stage pharmatech company using AI to design patient-based drugs.
– SoftBank Vision Fund 2 led the Series D funding round and was joined by previous round lead investors – Novo Holdings and funds managed by Blackrock.
– Other investors included Mubadala Investment Company, Farallon Capital, Casdin Capital, GT Healthcare Capital, Marshall Wace, Pivotal bioVenture Partners, Laurion Capital, Hongkou and Bristol-Myers Squibb.
– In addition to the Series D funding round, SoftBank is providing an additional $300m equity commitment that can be drawn at the company’s discretion.
– Exscientia is a clinical stage pharmatech company pioneering the use of artificial intelligence (AI) to design new drugs.
– Company raised 100m in Series C funding.
– The round was led by BlackRock with participation from Novo Holdings, Evotec, Bristol Myers Squibb, and GT Healthcare Capital.
– The company intends to use the funds for platform development towards autonomous drug design, extension of its proprietary pipeline into clinical trials and expansion of existing capabilities in biological analytics that support target selection and portfolio development.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Autobahn Therapeutics | $100M | 24 Jul 2024 | San Diego, California, United States | ||
Moon Surgical | $55M | 17 May 2023 | Paris, Ile-de-France, France | ||
Moon Surgical | $31M | 07 Jun 2022 | Paris, Ile-de-France, France | ||
| $105M | 28 Apr 2021 | San Diego, California, United States | |||
Exscientia | $40M | 04 Mar 2021 | Oxford, England, United Kingdom | ||
G.I. Windows | $16M | 19 Aug 2020 | Massachusetts, United States | ||
Exscientia | $60M | 26 May 2020 | Oxford, England, United Kingdom | ||
Oxford VR | $13M | 12 Feb 2020 | United Kingdom, England | ||
G.I. Windows | $14M | 11 Dec 2019 | Massachusetts, United States |
